M42, a global health leader powered by technology, AI and genomics, has announced a strategic partnership with 10X Health (USA) and REVIV Global (UK) to launch 10XREVIV, a pioneering venture set to ...

HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage ...

You’re driving through Kumasi when an unexpected accident occurs. Your vehicle collides with a luxury SUV, causing extensive damage. The repair bill? A staggering GHS45,000. Now imagine discovering ...